XT
HRTX icon

XTX Topco’s Heron Therapeutics HRTX Stock Holding History

XTX Topco’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-209,481
Closed -$168K – 4376
2026
Q1 		$168K Sell
209,481
-30,716
-13% -$35.6K ﹤0.01% 2911
2025
Q4 		$312K Buy
240,197
+209,700
+688% +$259K 0.01% 2028
2025
Q3 		$38.4K Buy
+30,497
New +$48.4K ﹤0.01% 2216
2025
Q2 		– Sell
-84,405
Closed -$186K – 2704
2025
Q1 		$186K Sell
84,405
-213,080
-72% -$414K 0.01% 1720
2024
Q4 		$455K Sell
297,485
-83
-0% -$135 0.04% 847
2024
Q3 		$592K Buy
297,568
+243,363
+449% +$581K 0.04% 704
2024
Q2 		$190K Sell
54,205
-154,582
-74% -$475K 0.02% 1262
2024
Q1 		$578K Buy
208,787
+104,513
+100% +$263K 0.08% 403
2023
Q4 		$177K Buy
+104,274
New +$115K 0.04% 1002
2023
Q3 		– Sell
-407,825
Closed -$473K – 1756
2023
Q2 		$473K Buy
407,825
+171,851
+73% +$306K 0.08% 403
2023
Q1 		$356K Sell
235,974
-111,063
-32% -$278K 0.07% 515
2022
Q4 		$868K Buy
347,037
+265,914
+328% +$857K 0.18% 116
2022
Q3 		$342K Buy
81,123
+3,039
+4% +$11.9K 0.08% 423
2022
Q2 		$218K Buy
78,084
+57,648
+282% +$231K 0.09% 433
2022
Q1 		$117K Buy
+20,436
New +$150K 0.05% 491
2021
Q4 		– Sell
-26,811
Closed -$287K – 827
2021
Q3 		$287K Buy
+26,811
New +$326K 0.1% 352
2021
Q2 		– Sell
-11,872
Closed -$192K – 931
2021
Q1 		$192K Buy
+11,872
New +$212K 0.09% 509

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

XTX Topco's HRTX Position: Q2 2026 in Review

XTX Topco sold out of Heron Therapeutics (HRTX) in Q2 2026, closing a stake of 209,481 shares — an estimated $168K sold.

XTX Topco first reported a position in HRTX in Q1 2021 and held it in 17 quarters. The position peaked at $868K in Q4 2022. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • XTX Topco reported no remaining Heron Therapeutics position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 209,481 Heron Therapeutics shares in Q2 2026, an estimated $168K.
  • XTX Topco first reported a position in Heron Therapeutics in Q1 2021 and held it in 17 quarters.
  • XTX Topco's Heron Therapeutics position peaked at $868K in Q4 2022.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.